advertisement

---

Qiu Y 8

Showing records 1 to 8 | Display all abstracts from Qiu Y

118831 Different concentrations of betaxolol switch cell fate between necroptosis, apoptosis, and senescence in human corneal stromal cells
Sun JY
Chemico-biological interactions 2024; 391: 110898

---

117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Li S
eLife 2024; 12:

---

118831 Different concentrations of betaxolol switch cell fate between necroptosis, apoptosis, and senescence in human corneal stromal cells
Zhao J
Chemico-biological interactions 2024; 391: 110898

---

117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Ren J
eLife 2024; 12:

---

118831 Different concentrations of betaxolol switch cell fate between necroptosis, apoptosis, and senescence in human corneal stromal cells
Qiu Y
Chemico-biological interactions 2024; 391: 110898

---

117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Jiang Z; Qiu Y
eLife 2024; 12:

---

118831 Different concentrations of betaxolol switch cell fate between necroptosis, apoptosis, and senescence in human corneal stromal cells
Fan TJ
Chemico-biological interactions 2024; 391: 110898

---

117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Shao M; Li Y; Wu J; Song Y; Sun X; Gao S; Cao W
eLife 2024; 12:

---